Rodney J. Hicks

40.2k total citations · 8 hit papers
602 papers, 23.8k citations indexed

About

Rodney J. Hicks is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Rodney J. Hicks has authored 602 papers receiving a total of 23.8k indexed citations (citations by other indexed papers that have themselves been cited), including 317 papers in Radiology, Nuclear Medicine and Imaging, 228 papers in Pulmonary and Respiratory Medicine and 217 papers in Oncology. Recurrent topics in Rodney J. Hicks's work include Medical Imaging Techniques and Applications (188 papers), Radiomics and Machine Learning in Medical Imaging (111 papers) and Radiopharmaceutical Chemistry and Applications (95 papers). Rodney J. Hicks is often cited by papers focused on Medical Imaging Techniques and Applications (188 papers), Radiomics and Machine Learning in Medical Imaging (111 papers) and Radiopharmaceutical Chemistry and Applications (95 papers). Rodney J. Hicks collaborates with scholars based in Australia, United States and United Kingdom. Rodney J. Hicks's co-authors include Michael S. Hofman, David Binns, Danny Rischin, David Ball, Grace Kong, Annette Hogg, Jason Callahan, Michael MacManus, Peter Eu and Michael P. Mac Manus and has published in prestigious journals such as New England Journal of Medicine, Angewandte Chemie International Edition and Circulation.

In The Last Decade

Rodney J. Hicks

591 papers receiving 23.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group

2014 989 citations Sally F. Barrington, N. George Mikhaeel et al. Journal of Clinical Oncology profile →
Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

2007 967 citations Malik E. Juweid, Sigrid Stroobants et al. Journal of Clinical Oncology profile →
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

2018 815 citations Michael S. Hofman, Rodney J. Hicks et al. profile →
Somatostatin Receptor Imaging with⁶⁸Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation

2015 383 citations Michael S. Hofman, Rodney J. Hicks et al. profile →
Dosimetry of ¹⁷⁷Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes

2018 339 citations Grace Kong, Rodney J. Hicks et al. Journal of Nuclear Medicine profile →
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging

2017 303 citations Anders Sundin, Éric Baudin et al. profile →
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma

2018 274 citations Rodney J. Hicks et al. profile →
Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls

2018 266 citations Michael S. Hofman, Rodney J. Hicks et al. profile →

Peers

Countries citing papers authored by Rodney J. Hicks

Since Specialization

Citations

This map shows the geographic impact of Rodney J. Hicks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodney J. Hicks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodney J. Hicks more than expected).

Fields of papers citing papers by Rodney J. Hicks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rodney J. Hicks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodney J. Hicks. The network helps show where Rodney J. Hicks may publish in the future.

Co-authorship network of co-authors of Rodney J. Hicks

This figure shows the co-authorship network connecting the top 25 collaborators of Rodney J. Hicks. A scholar is included among the top collaborators of Rodney J. Hicks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rodney J. Hicks. Rodney J. Hicks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Are FAP Theranostics Really Happening? Will Radiochemistry or Biology Win? 2025 ·Journal of Nuclear Medicine ·Rodney J. Hicks	3
2	Peptide receptor radionuclide therapy in malignant insulinoma 2025 ·Endocrine Related Cancer ·David A. Pattison, Grace Kong, Timothy Akhurst, Matthew Burge, Cherie Chiang, Michael S. Hofman, (unknown), (unknown), Michael Michael, Satomi Okano, Aravind S. Ravi Kumar, Nirupa Sachithanandan, David Wyld, Rodney J. Hicks	0
3	A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to ¹⁷⁷Lutetium-DOTA-octreotate radionuclide therapy 2023 ·Theranostics ·Kelly Waldeck, (unknown), Carleen Cullinane, Twishi Gulati, Kaylene J. Simpson, Richard W. Tothill, Benjamin J. Blyth, Rodney J. Hicks	6
4	The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors 2023 ·Journal of Nuclear Medicine ·Elif Hindié, Éric Baudin, Rodney J. Hicks, David Taïeb	3
5	MRD‐NEGATIVITY AFTER FRONTLINE DLBCL THERAPY: POOLED ANALYSIS OF 6 CLINICAL TRIALS 2023 ·Hematological Oncology ·Mark Roschewski, David M. Kurtz, Jason R. Westin, Ryan C. Lynch, Stefan Alig, Calum MacAulay, Christian Kuffer, (unknown), André Schultz, Sandra Close, (unknown), Davide Rossi, Stephen Opat, Rodney J. Hicks, Mark Hertzberg, Maximilian Diehn, Wyndham H. Wilson, Ash A. Alizadeh	5
6	Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial 2023 ·Cancer Imaging ·Samuel Tremblay, (unknown), Andrew Weickhardt, Ian D. Davis, Andrew M. Scott, Rodney J. Hicks, Ur Metser, Sue Chua, (unknown), Shonit Punwani, Heather Payne, Nina Tunariu, Bao Ho, (unknown), (unknown), Glenn Bauman, Louise Emmett, Frédéric Pouliot	1
7	ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours 2021 ·Journal of Neuroendocrinology ·Clarisse Dromain, Marie‐Pierre Vullierme, Rodney J. Hicks, Vikas Prasad, (unknown), Wouter W. de Herder, Marianne Pavel, Antongiulio Faggiano, Beata Kos‐Kudła, Kjell Öberg, Guenter J. Krejs, Enrique Grande, Bruno Niederle, Anders Sundin	13
8	ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours 2021 ·Journal of Neuroendocrinology ·Rodney J. Hicks, Clarisse Dromain, Wouter W. de Herder, Frederico Costa, Christophe M. Deroose, Andrea Frilling, Anna Koumarianou, Eric P. Krenning, Éric Raymond, Lisa Bodei, Halfdan Sørbye, Staffan Welin, Bertram Wiedenmann, Damian Wild, James R. Howe, James C. Yao, Dermot O’Toole, Anders Sundin, Vikas Prasad	13
9	Radionuclide imaging of NENs 2021 ·Current Opinion in Endocrine and Metabolic Research ·Grace Kong, Rodney J. Hicks	2
10	Modification of Biodistribution and Brain Uptake of Copper Bis(thiosemicarbazonato) Complexes by the Incorporation of Amine and Polyamine Functional Groups 2019 ·Inorganic Chemistry ·Brett M. Paterson, Carleen Cullinane, Peter J. Crouch, Anthony R. White, Kevin J. Barnham, Peter Roselt, (unknown), David Binns, Rodney J. Hicks, Paul S. Donnelly	25
11	Metabolic patterns and seizure outcomes following anterior temporal lobectomy 2019 ·Annals of Neurology ·(unknown), Benjamin Sinclair, Charles B. Malpas, Anne M. McIntosh, Zhibin Chen, Lucy Vivash, Marie O’Shea, Sarah J. Wilson, Patricia Desmond, Salvatore U. Berlangieri, Rodney J. Hicks, Christopher C. Rowe, Andrew Morokoff, James King, Gavin Fabinyi, Andrew H. Kaye, Patrick Kwan, Samuel F. Berkovic, Terence J. O’Brien	25
12	Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group breakdown → 2014 ·Journal of Clinical Oncology ·Sally F. Barrington, N. George Mikhaeel, Lale Kostakoğlu, Michel Meignan, Martin Hutchings, Stefan Müeller, Lawrence H. Schwartz, Emanuele Zucca, Richard I. Fisher, Judith Trotman, Otto S. Hoekstra, Rodney J. Hicks, Michael O’Doherty, Roland Hustinx, Alberto Biggi, Bruce D. Cheson	989
13	Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer 2012 ·Clinical Cancer Research ·Quynh‐Thu Le, Richard Fisher, Kelly S. Oliner, Richard J. Young, Hongbin Cao, Christina S. Kong, Edward E. Graves, Rodney J. Hicks, Grant A. McArthur, Lester Peters, Brian O’Sullivan, Amato J. Giaccia, Danny Rischin	41
14	Safety, Pharmacokinetic, and Pharmacodynamic Phase I Dose-Escalation Trial of PF-00562271, an Inhibitor of Focal Adhesion Kinase, in Advanced Solid Tumors 2012 ·Journal of Clinical Oncology ·Jeffrey R. Infante, D. Ross Camidge, Linda Mileshkin, Eric X. Chen, Rodney J. Hicks, Danny Rischin, Howard Fingert, Kristen J. Pierce, Huiping Xu, W. Gregory Roberts, S. Martin Shreeve, Howard A. Burris, Lillian L. Siu	195
15	Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non–Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib 2012 ·Clinical Cancer Research ·Elizabeth A. Punnoose, Siminder Atwal, Weiqun Liu, Rajiv Raja, Bernard M. Fine, Brett Hughes, Rodney J. Hicks, Garret M. Hampton, Lukas C. Amler, Andrea Pirzkall, Mark R. Lackner	341
16	Pretreatment Transcriptional Profiling for Predicting Response to Neoadjuvant Chemoradiotherapy in Rectal Adenocarcinoma 2011 ·Clinical Cancer Research ·Kate H. Brettingham‐Moore, Cuong Duong, Danielle Greenawalt, Alexander G. Heriot, Jason Ellul, (unknown), William K. Murray, Rodney J. Hicks, Joe J. Tjandra, Michael Chao, (unknown), Daryl Lim Joon, Robert J. S. Thomas, Wayne A. Phillips	43
17	In Vivo Activity of Combined PI3K/mTOR and MEK Inhibition in a KrasG12D ; Pten Deletion Mouse Model of Ovarian Cancer 2011 ·Molecular Cancer Therapeutics ·Kathryn M. Kinross, Daniel V. Brown, Margarete Kleinschmidt, Susan Jackson, James G. Christensen, Carleen Cullinane, Rodney J. Hicks, Ricky W. Johnstone, Grant A. McArthur	62
18	Changes in 18F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine Positron Emission Tomography Imaging in Patients with Non–Small Cell Lung Cancer Treated with Erlotinib 2011 ·Clinical Cancer Research ·Linda Mileshkin, Rodney J. Hicks, Brett Hughes, Paul Mitchell, Veena Charu, Barbara J. Gitlitz, David Macfarlane, Benjamin Solomon, Lukas C. Amler, Wei Yu, Andrea Pirzkall, Bernard M. Fine	106
19	Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma breakdown → 2007 ·Journal of Clinical Oncology ·Malik E. Juweid, Sigrid Stroobants, Otto S. Hoekstra, Felix M. Mottaghy, Markus Dietlein, Ali Guermazi, Gregory A. Wiseman, Lale Kostakoğlu, Klemens Scheidhauer, Andreas K. Buck, Ralph Naumann, Karoline Spaepen, Rodney J. Hicks, Wolfgang Weber, Sven N. Reske, Markus Schwaiger, Lawrence H. Schwartz, Josée M. Zijlstra, Barry A. Siegel, Bruce D. Cheson	967
20	Abstracts of Communications 1984 ·Proceedings of The Nutrition Society ·Rodney J. Hicks, (unknown), C. Tomlinson, John T. Gwynne, (unknown), K. S. Nandra, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact